Clinical trial
Vasoactive Intestinal Peptide in COPD
NCT00464932 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00464932 |
|---|---|
| Title | Vasoactive Intestinal Peptide in COPD |
| Acronym | VIPCOPD |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | COPD, Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Vasoactive Intestinal Peptide (VIP) |
| Enrollment | 34 |
| Start date | Jun 1, 2003 |
| Completion | Jul 1, 2006 |
| First posted | Apr 24, 2007 |
| Last update posted | Apr 24, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: